There are 4 versions of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Titles as Passed House

Ensuring Compliance Against Drug Diversion Act of 2020

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend the Controlled Substances Act to provide for the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances or list I chemicals, and for other purposes.


Actions Overview (4)

Date Actions Overview
11/17/2020Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5819)
11/16/2020Committee on the Judiciary discharged.
11/16/2020Reported by the Committee on Energy and Commerce. H. Rept. 116-584, Part I.
10/23/2019Introduced in House

All Actions (16)

Date Chamber All Actions
11/18/2020SenateReceived in the Senate and Read twice and referred to the Committee on the Judiciary.
11/17/2020-1:43pmHouseMotion to reconsider laid on the table Agreed to without objection.
11/17/2020-1:43pmHouseOn motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5819)
11/17/2020-1:36pmHouseDEBATE - The House proceeded with forty minutes of debate on H.R. 4812.
11/17/2020-1:36pmHouseConsidered under suspension of the rules. (consideration: CR H5819-5820)
11/17/2020-1:36pmHouseMr. Pallone moved to suspend the rules and pass the bill, as amended.
11/16/2020HousePlaced on the Union Calendar, Calendar No. 482.
11/16/2020HouseCommittee on the Judiciary discharged.
11/16/2020HouseReported by the Committee on Energy and Commerce. H. Rept. 116-584, Part I.
09/09/2020HouseOrdered to be Reported by Voice Vote.
Action By: Committee on Energy and Commerce
09/09/2020HouseCommittee Consideration and Mark-up Session Held.
Action By: Committee on Energy and Commerce
11/15/2019HouseReferred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Action By: Committee on the Judiciary
10/26/2019HouseReferred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
10/23/2019HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
10/23/2019HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
10/23/2019HouseIntroduced in House

Cosponsors (1)

* = Original cosponsor
CosponsorDate Cosponsored
Rep. Walden, Greg [R-OR-2] 10/28/2019

Committees (3)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce10/23/2019 Referred to
09/09/2020 Markup by
11/16/2020 Reported by H. Rept. 116-584
House Energy and Commerce Subcommittee on Health10/26/2019 Referred to
House Judiciary10/23/2019 Referred to
11/16/2020 Discharged from
House Judiciary Subcommittee on Crime, Terrorism, and Homeland Security11/15/2019 Referred to
Senate Judiciary11/18/2020 Referred to

As of 12/11/2020 no related bill information has been received for H.R.4812 - Ensuring Compliance Against Drug Diversion Act of 2020


Subjects (4)


Latest Summary (0)

A summary is in progress.